Optimization of chemical libraries by neural networks

Current Opinion in Chemical Biology

Volumn 4, Issue 3, 2000, Pages 280-282

  Sadowski, Jens ^a  

^a BASF SE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL NEURAL NETWORK; CHEMICAL MODIFICATION; MATHEMATICAL MODEL; MOLECULAR MODEL; ORGANIC CHEMISTRY; PREDICTION; REVIEW; TECHNOLOGY;

EID: 0034038901     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(00)00089-2     Document Type: Review

References (19)

1. Warr W.A.J. Combinatorial chemistry and molecular diversity. An overview. Chem Inf Comput Sci. 37:1997;134-140.
2. Zupan J., Gasteiger J. Neural Networks for Chemists: An Introduction. 1993;VCH Publishers, Weinheim.
3. Zell A. Simulation neuronaler Netze. 1994;Addison - Wesley, Reading, MA. [Title translation: Simulation of neural networks.].
4. Anzali S., Gasteiger J., Holzgrabe U., Polanski J., Sadowski J., Teckentrup A., Wagener M. The use of self-organizing neural networks in drug design. Perspect Drug Discov Des. 9-11:1998;273-299.
5. Burden F.R., Winkler D.A. Robust QSAR models using Bayesian regularized neural networks. J Med Chem. 42:1999;3183-3187. An extension of conventional neural networks that enables better quality control.
6. Bayada D.M., Hamersma H., van Geerestein V.J. Molecular diversity and representativity in chemical databases. J Chem Inf Comput Sci. 39:1999;1-10.
7. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev. 23:1997;3-25.
8. Gillet V.J., Bradshaw J. Identification of biological activity profiles using substructural analysis and genetic algorithms. J Chem Inf Comput Sci. 38:1998;165-179.
9. Ajay Q., Walters W.P., Murcko M.A. Can we learn to distinguish between "drug-like" and nondrug-like molecules? J Med Chem. 41:1998;3314-3324.
10. Sadowski J., Kubinyi H. A scoring scheme for discriminating between drugs and nondrugs. J Med Chem. 41:1998;3325-3329.
11. Wang J., Ramnarayan K. Toward designing drug-like libraries: a novel computational approach for prediction of drug feasibility of compounds. J Comb Chem. 1:1999;524-533.
12. Walters W.P., Ajay Q., Murcko M.A. Recognising molecules with drug like properties. Curr Opin Chem Biol. 3:1999;384-387. A comprehensive overview of methods for assessment of drug-likeness as a general compound property.
13. Sadowski J. Database profiling by neural networks. Böhm H.J., Schneider G. Virtual Screening for Bioactive Molecules. 2000;Wiley-VCH, New York. in press.
14. Schneider G., Coassolo P., Lavé T. Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques. J Med Chem. 42:1999;5072-5076.
15. Gini G., Lorenzini M. Predictive carcinogenicity: a model for aromatic compounds, with nitrogen-containing substituents, based on molecular descriptors using an artificial neural network. J Chem Inf Comput Sci. 39:1999;1076-1080.
16. •]) can also be applied to more specialized data.
17. Burden F.R., Winkler D.A. New QSAR methods applied to structure-activity mapping and combinatorial chemistry. J Chem Inf Comput Sci. 39:1999;236-242.
18. Gillet V.J., Willett P., Bradshaw J., Green D.V.S. Selecting combinatorial libraries to optimize diversity and physical properties. J Chem Inf Comput Sci. 39:1999;169-177.
19. Sadowski J. Optimization of the drug-likeness of chemical libraries. Persp Drug Discov Des. 2000;. in press.